Medications

Sanofi acquires over-the-counter rights for Cialis

French drugmaker Sanofi is buying the rights to seek approval for a version of the erectile dysfunction drug Cialis that customers would be able to buy without a doctor's prescription.

Diabetes

No increased cancer risk with glargine versus human insulin

(HealthDay)—There is no evidence that patients with diabetes who initiate insulin glargine have a higher risk of cancer than similar patients initiating human neutral protamine Hagedorn (NPH) insulin, according to a study ...

Diseases, Conditions, Syndromes

Dengue vaccine to be tested in India

French health care giant Sanofi Pasteur will soon test a vaccine against dengue fever in India amid concerns about the increasingly global spread of the disease, reports said Monday.

Other

Single topical ivermectin head lice treatment very effective

(HealthDay)—A single 10-minute, at-home treatment with topical ivermectin lotion eliminates head lice infestations in nearly all patients by the next day, according to a study published in the Nov. 1 issue of the New England ...

Medical research

Greater drop in LDL seen with atorvastatin plus PCSK9 antibody

(HealthDay)—Addition of the fully human serum proprotein convertase subtilisin/kexin 9 monoclonal antibody, SAR236553, to atorvastatin is associated with greater reductions in low-density lipoprotein (LDL) cholesterol levels ...

Medications

Class action against Sanofi wins French court backing

A French court on Wednesday allowed a class-action lawsuit to go ahead against pharmaceutical giant Sanofi by families of victims of Depakine, an epilepsy drug that can severely damage foetal development.

page 7 from 13